News Headlines Article

New transparency requirements, loss of safe harbor for PBMs and drugmakers in proposed rule
Modern Healthcare

The Trump administration is calling for pharmacy benefit managers to disclose to health plans the fees that they get from drug companies for administrative services as part of a bid to boost transparency among PBMs. The fee transparency requirement is part of a proposed rule unveiled last week that also would eliminate anti-kickback statute safe harbor protections for drug rebates, while creating two new ones. The rule proposes to create a safe harbor for discounts provided at the point of sale at pharmacy counters and another for fees that drugmakers pay to PBMs for certain services.